The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Works matching IS 00278874 AND DT 2008 AND VI 100 AND IP 21
Results: 18
1
2
Response.
- Published in:
- 2008
- By:
- Publication type:
- Letter
3
Re: Should Supplemental Antioxidant Administration Be Avoided During Chemotherapy and Radiation Therapy?
- Published in:
- 2008
- By:
- Publication type:
- Letter
4
Re: Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma.
- Published in:
- 2008
- By:
- Publication type:
- Letter
5
Re: Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma.
- Published in:
- 2008
- By:
- Publication type:
- Letter
6
The CHRNA5-A3 Region on Chromosome 15q24-25..1 Is a Risk Factor Both for Nicotine Dependence and for Lung Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 21, p. 1552, doi. 10.1093/jnci/djn363
- By:
- Publication type:
- Article
7
Characteristics of US Patients with Myelodysplastic Syndromes: Results of Six Cross-sectional Physician Surveys.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 21, p. 1542, doi. 10.1093/jnci/djn349
- By:
- Publication type:
- Article
8
Refinement and Psychometric Evaluation of the Impact of Cancer Scale.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 21, p. 1530, doi. 10.1093/jnci/djn340
- By:
- Publication type:
- Article
9
Skewed X Chromosome Inactivation and Breast and Ovarian Cancer Status: Evidence for X-Linked Modifiers of BRCA1.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 21, p. 1519, doi. 10.1093/jnci/djn345
- By:
- Publication type:
- Article
10
The Influence of Statin Medications on Prostate-specific Antigen Levels.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 21, p. 1511, doi. 10.1093/jnci/djn362
- By:
- Publication type:
- Article
11
Antitumor Efficacy Testing in Rodents.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 21, p. 100, doi. 10.1093/jnci/djn351
- By:
- Publication type:
- Article
12
Awards, Appointments, Announcements.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 21, p. 1499, doi. 10.1093/jnci/djn399
- Publication type:
- Article
13
Distribution of Melanoma Incidence and Mortality by Age, 2001-2005.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 21, p. 1498, doi. 10.1093/jnci/djn393
- Publication type:
- Article
14
Proton Therapy Use Incites Debate Over Clinical Trials.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 21, p. 1496, doi. 10.1093/jnci/djn401
- By:
- Publication type:
- Article
15
Watchful Waiting Beats Androgen Deprivation Therapy in Early Prostate Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 21, p. 1494, doi. 10.1093/jnci/djn402
- By:
- Publication type:
- Article
16
Virtual Colonoscopy Accepted As Primary Colon Cancer Screening Test.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 21, p. 1492, doi. 10.1093/jnci/djn403
- By:
- Publication type:
- Article
17
Intermediacy and Gene-Environment Interaction: The Example of CHRNA5-A3 Region, Smoking, Nicotine Dependence, and Lung Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 21, p. 1488, doi. 10.1093/jnci/djn380
- By:
- Publication type:
- Article
18
Prostate-Specific Antigen: A Misused and Maligned Prostate Cancer Biomarker.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 21, p. 1487, doi. 10.1093/jnci/djn368
- By:
- Publication type:
- Article